Status:
COMPLETED
Serum Endocan Levels and Gestational Diabetes
Lead Sponsor:
Gaziosmanpasa Research and Education Hospital
Conditions:
Gestational Diabetes
Endocan
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
In diabetic patients, serum endocan level has been significantly increased in patients and the levels on the long-term complications are correlated. Based on the Iinformation obtained from these studi...
Detailed Description
It has been shown that endocan level of plasental tissue in gestational diabtes patients is significantly increased when looking at the same week compared with plasenta tissue samples of helathy pregn...
Eligibility Criteria
Inclusion
- being pregnant at 24-26 weeks of gestation
- having oral glucose toleranse screening test
- age between 18-45 years
Exclusion
- having in utero mort fetus
- having a previous diagnosis of diabetes
- having a multiple pregnancy
- having a coronary artery disease
- having preeclampcia
- having a pregnancy obtained by assisted reproductive technology
- using cigarette
- using alcohol
Key Trial Info
Start Date :
March 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 5 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05237895
Start Date
March 3 2022
End Date
May 5 2022
Last Update
August 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaziosmanpaşa Treh
Istanbul, Gaziosmanpaşa, Turkey (Türkiye), 34000